德展健康
(000813)
| 流通市值：58.66亿 | | | 总市值：58.67亿 |
| 流通股本：21.65亿 | | | 总股本：21.65亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 498,088,171.28 | 335,143,687.81 | 220,809,774.68 | 135,160,087.88 |
| 营业收入 | 498,088,171.28 | 335,143,687.81 | 220,809,774.68 | 135,160,087.88 |
| 二、营业总成本 | 468,292,393.88 | 328,972,818.54 | 207,603,670.04 | 122,728,241.6 |
| 营业成本 | 205,535,638.92 | 136,432,990.24 | 85,738,551.57 | 58,219,432.66 |
| 税金及附加 | 11,467,467.09 | 9,071,318.04 | 5,894,489.8 | 3,918,224.2 |
| 销售费用 | 91,603,136.08 | 65,687,800.69 | 41,495,247.94 | 26,048,241.63 |
| 管理费用 | 173,559,265.33 | 126,863,595.37 | 77,846,959.67 | 41,637,401.97 |
| 研发费用 | 51,095,963.9 | 37,686,122.01 | 26,259,832.69 | 11,907,421.27 |
| 财务费用 | -64,969,077.44 | -46,769,007.81 | -29,631,411.63 | -19,002,480.13 |
| 其中:利息费用 | 365,894.26 | 302,921.58 | 235,054.36 | 177,774.72 |
| 其中:利息收入 | 68,006,940.85 | 51,141,106.34 | 34,448,059.48 | 18,546,268.72 |
| 加:投资收益 | 80,311,589.36 | 62,154,545.86 | -8,468,159.56 | -4,423,640.25 |
| 资产处置收益 | -34,109.82 | -1,068.87 | - | - |
| 资产减值损失(新) | -21,990,168.41 | -14,160,403.6 | -15,732,030.23 | 225,410.17 |
| 信用减值损失(新) | -12,570,742.93 | -9,776,037.58 | -7,563,908.66 | -1,373,365.76 |
| 其他收益 | 4,711,536.08 | 2,242,670.62 | 1,816,850.96 | 796,386.79 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 80,223,881.68 | 46,630,575.7 | -16,741,142.85 | 7,656,637.23 |
| 加:营业外收入 | 3,002,081.9 | 2,981,727.7 | 155,934.99 | 3,206.05 |
| 减:营业外支出 | 1,385,170.22 | 1,159,408.77 | 639,187.37 | 469,823.86 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 81,840,793.36 | 48,452,894.63 | -17,224,395.23 | 7,190,019.42 |
| 减:所得税费用 | 27,599,099.84 | 10,035,549.59 | 9,099,292.55 | 6,607,411.31 |
| 六、净利润 | 54,241,693.52 | 38,417,345.04 | -26,323,687.78 | 582,608.11 |
| 持续经营净利润 | 54,241,693.52 | 38,417,345.04 | -26,323,687.78 | 582,608.11 |
| 归属于母公司股东的净利润 | 83,314,246.81 | 61,365,294.29 | -7,564,371.15 | 1,859,373.76 |
| 少数股东损益 | -29,072,553.29 | -22,947,949.25 | -18,759,316.63 | -1,276,765.65 |
| (一)基本每股收益 | 0.04 | 0.03 | 0 | 0 |
| (二)稀释每股收益 | 0.04 | 0.03 | 0 | 0 |
| 八、其他综合收益 | -2,125,000 | - | - | - |
| 归属于母公司股东的其他综合收益 | -2,125,000 | - | - | - |
| 九、综合收益总额 | 52,116,693.52 | 38,417,345.04 | -26,323,687.78 | 582,608.11 |
| 归属于母公司股东的综合收益总额 | 81,189,246.81 | 61,365,294.29 | -7,564,371.15 | 1,859,373.76 |
| 归属于少数股东的综合收益总额 | -29,072,553.29 | -22,947,949.25 | -18,759,316.63 | -1,276,765.65 |
| 公告日期 | 2024-04-12 | 2023-10-26 | 2023-08-24 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |